Overview
- 125 inspections across 111 sites are on record.
- 431 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2020-03-06.
At a glance
Inspections
125
Sites
111
Observations
431
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| KBI Biopharma, Inc. | 6 Mar 2020 | Human Drugs | On file |
| Septodont Inc. | 10 Feb 2020 | Human Drugs | |
| Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical | 20 Dec 2019 | Human Drugs | View 483 → |
| USL Pharma Inc. dba Upsher-Smith Laboratories, LLC | 7 Nov 2019 | Human Drugs | View 483 → |
| Boehringer Ingelheim Pharma GmbH and Co. KG | 19 Sep 2019 | Human Drugs | View 483 → |
Sites inspected
KBI Biopharma, Inc.Boulder, United States1 insp.
Septodont Inc.Louisville, United States1 insp.
Fusion IV Pharmaceuticals, Inc. dba Axia PharmaceuticalLos Angeles, United States1 insp.
USL Pharma Inc. dba Upsher-Smith Laboratories, LLCDenver, United States1 insp.
Boehringer Ingelheim Pharma GmbH and Co. KGBiberach An Der Ris, Germany1 insp.
Co-investigators
Investigators who share inspections with this person.
Kimberley A Hoefen10 shared
Zachery L Miller8 shared
Michele Perry Williams5 shared
Deyaa Shaheen4 shared
Isabel Y Espinosa4 shared
Kathleen B Swat4 shared
Shanna R Haden4 shared
Jason K Morgan3 shared
Pratik S Upadhyay3 shared
Michael E Maselli3 shared
Full investigator report
Get the verbatim findings behind Erika V Butler's 431 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site